Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 938-820-4 | CAS number: -
Endpoint summary
Administrative data
Description of key information
Lactamoil 70% has a pH of 12.5 and is intended for exclusive industrial use. Due to its corrosive properties as demonstrated by a Corrositex® assay (OECD Guideline 435), the test substance is classified as corrosive to the skin, category 1C (H314) according to Regulation (EC) 1272/2008 (CLP). The relevant health effect to be expected upon inhalative exposure is respiratory irritation, which indicates further classification as STOT SE, category 3 (H335: May cause respiratory irritation). Due to the corrosive properties of the substance and the resulting classification, a qualitative risk assessment for dermal corrosion needs to be performed in accordance with ECHA guidance document Part E (ECHA 2012). The guidance document advises allocation of substances classified as corrosive to the skin (category 1C) to the moderate hazard band (see table E.3.1), denominating notably stringent risk management measures and operational conditions. In any case, this qualitative approach effectively prevents from any significant dermal and/or inhalative exposure.
In conclusion, relevant human dermal exposure can be excluded in humans in accordance with annex XI, section 3 of Regulation (EC) 1907/2006 (REACH), which justifies waiving of repeated dose toxicity testing.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
